| Record no |
2022031136913 |
| Activity status |
Active |
| Working Title |
CLONING AND EXPRESSION OF IN-VIVO REFOLDED ANTIBODY FRAGMENT |
| Working Inventors |
RAHUL BHAMBURE; |
| Contributing institutions |
NCL |
| Administered by |
CSIR |
| Ownership |
|
| Categories > Subjects |
Chemical engineering and process development |
| Categories > Portfolio |
Medical biotechnology/bioprocess engineering |
| Disclosure number |
2018-INV-0086 |
| NCL No |
2019-NCL-0003 |
| CSIR No |
2019-NF-0023
|
| Priority date |
04-02-2019 |
| Country |
US |
| Application number |
17/600867 |
| Provisional filing date |
|
| Complete filing date |
10-01-2021 |
| Publication status |
Yes |
| Publication date |
06-09-2022 |
| Publication no |
US 2022/0177562 A1 |
| Granted number |
|
| Granted date |
|
| Final title |
CLONING AND EXPRESSION OF IN-VIVO REFOLDED ANTIBODY FRAGMENT |
| Final Inventors |
RAHUL SHARAD BHAMBURE;AATIR ASAD TUNGEKAR; |
| Abstract |
|
| Case status |
Complete specification filed |
| Licensing status |
|
| Licensing case no |
|
| Client name |
|
| Lead inventors |
RAHUL S BHAMBURE |
| Categories > Industry > Primary |
|
| Categories > Industry > other |
|